Cancer Genomics Consortium

Analysis

Cancer Genomics Consortium is a registered charity in United States, based in Fletcher, NC. It received its IRS tax-exemption ruling in March 2014, 12 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cancer Genomics Consortium reported income of $441k and spending of $447k, spending 101% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $327k to $441k (+35%), an average of +7.7% a year. The sharpest change came in the year to December 2021, when income rose by 86%. Over the whole period it spent 87% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cancer Genomics Consortium sits at the 53rd percentile: it is larger than about 53% of them. Against every charity in United States with reported income it ranks in the 68th percentile, and in the 67th percentile within NC. Charities of a similar size with the same main cause include Renew Clinic ($441k), Lewisboro Volunteer Ambulance Corps Inc ($441k) and One Recovery ($441k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 1.5% and program service revenue 93% of the total. At year end it held assets of $580k against liabilities of $74k, net assets of $507k.